Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Simeprevir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Achillion gets $15M milestone payment from Janssen for advancement of HCV drug
    Achillion gets $15M milestone payment from Janssen for advancement of HCV drug

    29 Dec 2016

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=99536&sid=2

    PHARMABIZ
    29 Dec 2016
    Share Share
    EU Health Regulator Warns Some Hep C Drugs Could Reactivate Hep B
    EU Health Regulator Warns Some Hep C Drugs Could Reactivate Hep B

    03 Dec 2016

    // VL Nathan REUTERS

    http://www.reuters.com/article/us-eu-hepatitis-idUSKBN13R1T7

    VL Nathan REUTERS
    03 Dec 2016
    Share Share
    Recent Success in HCV Treatment Brings Relief to Patients
    Recent Success in HCV Treatment Brings Relief to Patients

    07 Nov 2016

    // DRUG DEVELOPMENT

    http://www.drug-dev.com/Main/Back-Issues/HCV-MARKET-Recent-Success-in-HCV-Treatment-Brings-1213.aspx

    DRUG DEVELOPMENT
    07 Nov 2016
    Share Share
    Japan's PMDA reviews hep B risk link to hep C therapies
    Japan's PMDA reviews hep B risk link to hep C therapies

    04 May 2016

    // EJ Lane FIERCE ASIA

    http://www.fiercepharma.com/pharma-asia/japan-s-pmda-reviews-hep-b-risk-link-to-hep-c-therapies

    EJ Lane FIERCE ASIA
    04 May 2016
    Share Share
    EU extends safety review of chronic Hep C treatments
    EU extends safety review of chronic Hep C treatments

    15 Apr 2016

    // Vidya L Nathan REUTERS

    http://www.reuters.com/article/us-eu-hepatitis-c-idUSKCN0XC1MB

    Vidya L Nathan REUTERS
    15 Apr 2016
    Share Share
    Switching study gives Celltrion biosim more ammo in fight for Remicade share
    Switching study gives Celltrion biosim more ammo in fight for Remicade share

    21 Mar 2016

    // Carly Helfand FIERCE PHARMA MARKETING

    http://www.fiercepharmamarketing.com/story/switching-study-gives-celltrion-biosim-more-ammo-fight-remicade-share/2016-03-21

    Carly Helfand FIERCE PHARMA MARKETING
    21 Mar 2016
    Share Share